Document is current

Any future updates will be listed below

948 A multi-integrin targeting peptide-drug conjugate induces durable tumor regression with a strong preclinical safety profile

Crossref DOI link: https://doi.org/10.1136/jitc-2025-SITC2025.0948

Published Online: 2025-11-04

Published Print: 2025-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark